We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Mild versus severe immune response during COVID-19 infection (Photo courtesy of Wikimedia Commons)

Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26

Increased systemic IL-26 was found to be associated with markers of hyperinflammation and tissue damage in patients with acute COVID-19, suggesting that it may be a potential target for diagnosis, monitoring, and therapy in this disease. More...
22 Nov 2022
Image: The developed micro-costing framework. cfDNA, cell-free DNA; ctDNA, circulating tumor DNA (Photo courtesy of the Amsterdam University Medical Centers)

New Tool Assesses Cost of ctDNA Testing

Circulating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. Estimating total cost of ctDNA testing is necessary for reimbursement and implementation, but challenging because of variations in workflow. More...
22 Nov 2022
Image: The Xpert Xpress MVP PCR test aids in faster identification of three distinct conditions within an hour (Photo courtesy of Cepheid)

Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour

A new multiplexed PCR test detects DNA from organisms associated with three distinct conditions – bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis – from a single sample, aiding in more accurate diagnosis and antibiotic treatment regimens. More...
22 Nov 2022
Image: EONIS SCID-SMA kit is the first U.S. FDA authorized assay for SMA screening in newborns (Photo courtesy of PerkinElmer)

Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns

PerkinElmer, Inc. (Waltham, MA, USA) has received US FDA authorization for the marketing of its EONIS SCID-SMA assay kit for in vitro diagnostic (IVD) use by certified laboratories for the simultaneous detection of SMA and SCID in newborns. More...
22 Nov 2022
Image: Liver cancer is the third-leading cause of cancer-related deaths worldwide (Photo courtesy of Delfi Diagnostics)

Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population

A new study has shown that a test which is easy to perform with a routine blood sample and relatively low cost could more than double the number of liver cancer cases detected in a high-risk population compared to today's standard of care – a mix of ultrasound imaging and protein tests that few patients receive. More...
22 Nov 2022
Image: The Clarifi mTBI saliva test collection device (Photo courtesy of Quadrant Biosciences)

First-Ever Saliva-Based Concussion Test to Be Available in 2023

Currently, there are no biological tests to diagnose mild traumatic brain injury (mTBI) or concussion. Now, new research has revealed that biomarkers found in saliva may distinguish mTBI and parallel symptom recovery. More...
21 Nov 2022
Image: Liver cancer is the third leading cause of cancer deaths worldwide (Photo courtesy of Pexels)

AI Blood Test Detects Liver Cancer

A novel artificial intelligence blood testing technology developed by researchers to successfully detect lung cancer in a 2021 study has detected more than 80% of liver cancers in a new study of 724 people. More...
21 Nov 2022
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Urine Strips
11 Parameter Urine Strips
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.